Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-11-28 4:05 pm Sale | 13G | ANNOVIS BIO INC ANVS | HIRSCHMAN ORIN | 470,000 4.58% | -103,941 (-18.11%) | View |
2023-11-08 07:02 am Purchase | 13G | ANNOVIS BIO INC ANVS | HIRSCHMAN ORIN | 573,941 5.6% | 245,583 (+74.79%) | View |
2023-10-11 12:28 pm Purchase | 13G | VACCINEX INC VCNX | HIRSCHMAN ORIN | 1,233,382 9.9% | 1,233,382 (New Position) | View |
2023-09-29 2:16 pm Purchase | 13G | CAPSTONE GREEN ENERGY CORPORAT CGRN | HIRSCHMAN ORIN | 1,800,000 9.8% | 1,800,000 (New Position) | View |
2023-09-20 4:38 pm Purchase | 13G | DROR ORTHO-DESIGN, INC. DROR | HIRSCHMAN ORIN | 48,662,500 9.8% | 48,662,500 (New Position) | View |
2023-09-07 06:01 am Purchase | 13G | MYOMO INC MYO | HIRSCHMAN ORIN | 2,540,000 9.6% | 540,000 (+27.00%) | View |
2023-08-30 4:05 pm Purchase | 13G | SOLENO THERAPEUTICS INC NE SLNO | HIRSCHMAN ORIN | 498,610 4.9% | 76,121 (+18.02%) | View |
2023-08-14 08:00 am Purchase | 13G | APYX MED CORP COM APYX | HIRSCHMAN ORIN | 1,884,281 5.4% | 197,805 (+11.73%) | View |
2023-06-14 07:01 am Purchase | 13G | BRAINSWAY LTD SPONSORED ADS BWAY | HIRSCHMAN ORIN | 1,005,435 6.1% | 1,005,435 (New Position) | View |
2023-06-12 8:59 pm Sale | 13G | APYX MED CORP COM APYX | HIRSCHMAN ORIN | 1,686,476 4.9% | -309,524 (-15.51%) | View |
2023-05-15 06:07 am Purchase | 13G | GSI TECHNOLOGY GSIT | HIRSCHMAN ORIN | 2,000,000 8.1% | 2,000,000 (New Position) | View |
2023-05-12 06:42 am Purchase | 13G | APYX MED CORP COM APYX | HIRSCHMAN ORIN | 1,996,000 5.8% | 1,996,000 (New Position) | View |
2023-04-03 08:11 am Sale | 13G | SCYNEXIS INC SCYX | HIRSCHMAN ORIN | 1,159,346 3.5% | -772,700 (-39.99%) | View |
2023-03-21 4:05 pm Purchase | 13G | BIODESIX INC BDSX | HIRSCHMAN ORIN | 5,568,901 7.1% | 5,568,901 (New Position) | View |
2023-03-20 08:08 am Sale | 13G | PARATEK PHARMACEUTICAL, INC CO PRTK | HIRSCHMAN ORIN | 2,802,115 4.9% | -1,354,776 (-32.59%) | View |
2023-03-03 06:03 am Purchase | 13G | APREA THERAPEUTICS INC APRE | HIRSCHMAN ORIN | 345,000 11% | 345,000 (New Position) | View |
2023-02-15 07:26 am Sale | 13G | SOLENO THERAPEUTICS INC NE SLNO | HIRSCHMAN ORIN | 422,489 5.2% | -6,377,511 (-93.79%) | View |
2023-02-15 07:18 am Purchase | 13G | PARATEK PHARMACEUTICAL, INC CO PRTK | HIRSCHMAN ORIN | 4,156,891 7.5% | 269,719 (+6.94%) | View |
2023-02-15 07:12 am Unchanged | 13G | KWESST MICRO SYS INC KWE | HIRSCHMAN ORIN | 400,000 9.9% | 0 (Unchanged) | View |
2023-02-15 07:06 am Sale | 13G | DZS INC DZSI | HIRSCHMAN ORIN | 1,487,953 4.83% | -80,391 (-5.13%) | View |